Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Gattinoni

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Cytotherapy|April 21, 2025
CAR T cells re-directed by a rationally designed human peptide tag demonstrate efficacy in preclinical modelsNele Knelangen, Ulrika Bader, Evangelia Maniaki, et al.
Blood|September 19, 2008
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriersAndrea Boni, Pawel Muranski, Lydie Cassard, et al.
Cell Reports|September 15, 2015
TCF1 Is Required for the T Follicular Helper Cell Response to Viral InfectionTuoqi Wu, Hyun Mu Shin, E Ashley Moseman, et al.
Blood|February 16, 2008
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapyChristian S Hinrichs, Rosanne Spolski, Chrystal M Paulos, et al.
Nature Medicine|June 16, 2009
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cellsLuca Gattinoni, Xiao-Song Zhong, Douglas C Palmer, et al.
JCI Insight|September 21, 2018
Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunityKarolina Pilipow, Eloise Scamardella, Simone Puccio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in miceChristopher A Klebanoff, Luca Gattinoni, Douglas C Palmer, et al.
Nature Communications|December 16, 2017
Ezh2 phosphorylation state determines its capacity to maintain CD8<sup>+</sup> T memory precursors for antitumor immunityShan He, Yongnian Liu, Lijun Meng, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2005
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cellsChristopher A Klebanoff, Luca Gattinoni, Parizad Torabi-Parizi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Cytotherapy|April 21, 2025
CAR T cells re-directed by a rationally designed human peptide tag demonstrate efficacy in preclinical modelsNele Knelangen, Ulrika Bader, Evangelia Maniaki, et al.
Blood|September 19, 2008
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriersAndrea Boni, Pawel Muranski, Lydie Cassard, et al.
Cell Reports|September 15, 2015
TCF1 Is Required for the T Follicular Helper Cell Response to Viral InfectionTuoqi Wu, Hyun Mu Shin, E Ashley Moseman, et al.
Blood|February 16, 2008
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapyChristian S Hinrichs, Rosanne Spolski, Chrystal M Paulos, et al.
Nature Medicine|June 16, 2009
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cellsLuca Gattinoni, Xiao-Song Zhong, Douglas C Palmer, et al.
JCI Insight|September 21, 2018
Antioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunityKarolina Pilipow, Eloise Scamardella, Simone Puccio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in miceChristopher A Klebanoff, Luca Gattinoni, Douglas C Palmer, et al.
Nature Communications|December 16, 2017
Ezh2 phosphorylation state determines its capacity to maintain CD8<sup>+</sup> T memory precursors for antitumor immunityShan He, Yongnian Liu, Lijun Meng, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2005
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cellsChristopher A Klebanoff, Luca Gattinoni, Parizad Torabi-Parizi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destructionDouglas C Palmer, Sanjeeve Balasubramaniam, Ken-Ichi Hanada, et al.
Pageof 12